Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. Continue Reading….
Genomenon®, home of the Mastermind® Genomic Search Engine, announced its participation at the 2020 Digital Health & Medtech Showcase being held in San Francisco, California January 13th – 15th, 2020 in parallel with the Biotech Showcase™ 2020 and the 38th annual J.P. Morgan Healthcare Conference. Continue Reading….
November 6, 2019 – Genomenon Accelerates Rare and Genetic Disease Research with Mastermind Version 2.0
Genomenon® announced the release of Mastermind® version 2.0 today. The Genomic Search Engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases. Continue Reading….
Genomenon® announced today a partnership with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search Engine into the SOPHiA Platform and the Alamut Suite. With the addition of Mastermind, users of both technologies will be able to quickly access the genomic evidence associated with human variants, shortening the search time required to interpret a variant and assess its pathogenicity. Continue Reading….
October 2, 2019 – Congenica Partners with Genomenon to Integrate Mastermind into Congenica Clinical Platform
Genomenon® announced a partnership with Congenica Ltd today that incorporates Mastermind® Genomic Search Engine results into Congenica’s industry-leading clinical decision support platform for genomic data interpretation. The goal of the partnership is to put the most up-to-date genomic research at the fingertips of geneticists diagnosing genetic diseases. Continue Reading….
Congenica Ltd, a digital health technology company enabling accelerated interpretation of complex genomic data to improve disease diagnosis, has announced significant developments to its software solution, with the integration of powerful new reference data sources, DECIPHER and Mastermind® into its clinical decision support platform. Continue Reading….
Genomenon®, today announced a partnership with rare disease advocacy group BPAN Warriors, with the goal of providing resources to assist researchers and encourage pharmaceutical companies to invest in finding efficacious treatments for Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a progressive disease causing abnormal iron deposits in the brain. Continue Reading….
August 20, 2019 – Genomenon, Shanghai Shanyi Announce Strategic Partnership to Bring Leading Genomic Search Engine to the China Market
Genomenon, Inc. and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China. Genomenon’s Mastermind is the leading genomic search engine on the market. With nearly 3,500 users in over 100 countries, Mastermind has become the search engine of choice when researching patient variants for clinical NGS interpretation. Continue Reading….
Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small Business Innovation Research (SBIR) grant, awarded by the National Human Genome Research Institute*, will fund Genomenon’s further innovation in automating aspects of genomic interpretation from the research literature, and the creation of a platform for producing and sharing “micropublications” across the genomics community. Continue Reading….
Genomenon, Inc., has been issued a patent from the United States Patent and Trademark Office for “Systems and Methods for Electronically Mining Genomic Data”. The patent covers the technology used to mine disease, gene, and genetic mutation and the relationships between diseases and mutations from the scientific literature. Continue Reading….
June 10, 2019 – Fusion Genes Found to be an Emerging Target in Cancer Diagnostics and Drug Development
Genomenon has released a research report detailing fusion genes of clinical significance. Fusion genes have long been known to play an important role in the development of cancer. Identifying and documenting each newly discovered fusion is crucial in both patient diagnosis and the development of precision medicines (specifically, targeted therapeutics). The report was compiled using research data found in the Mastermind Genomic Search Engine. Continue Reading….
Genomenon announced today that Keck Graduate Institute (KGI) has become the first academic partner in their new Genomics Educator Program. Genomenon is the creator of the Mastermind Genomic Search Engine, which provides insight into the published genomic research for every disease, gene, and variant found in the scientific literature. Continue Reading….
Widely considered one of the most prestigious business awards programs in the U.S., the program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world. Klein was selected as a finalist by a panel of independent judges. Continue Reading….
Genomenon Inc., the leading genomic search company, today announced that Bio-IT World has awarded them Best of Show for the Mastermind Genomic Search Engine. During the April 18th awards ceremony, Mastermind was applauded as a product that was unique, important to the industry, and offered a compelling return on investment. Continue Reading….
April 16, 2019 – Genomenon Partners with Google to Make Genomic Data Available on Google Cloud Platform
Genomenon, Inc. announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud Platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big data and machine learning data warehouse, for use in genomic applications. Continue Reading….
April 2, 2019 – LifeMap Sciences and Genomenon Partner to Integrate Mastermind Genomic Search Engine into GeneCards Suite and TGex
LifeMap Sciences, the leading integrated biomedical knowledgebase company and a leading provider of tertiary NGS analysis and interpretation solutions for genetic disorders, and Genomenon, the leading genomic search company, announced today that they have entered into a partnership to improve LifeMap’s GeneCards knowledgebase and provide accelerated interpretation of genetic disorders by integrating the Mastermind Genomic Search Engine. Continue Reading….
Genomenon has been recognized as one of the 2019 “Michigan 50 Companies to Watch,” an awards program presented by Michigan Celebrates Small Business. Selected companies like Genomenon are known for their exceptional entrepreneurial leadership, creation of innovation or use of innovation in creative ways, and their sustainable competitive advantage. Continue Reading….
February 28, 2019 – Rare Genomics Institute Demonstrates the Power of Genomenon’s AI-Based Technology in Diagnosis
Rare Genomics Institute, a nonprofit providing direct support to undiagnosed rare disease patients, announced on Rare Disease Day that they were able to diagnose a previously undiagnosed patient with the use of the Mastermind Genomic Search Engine, a clinical decision support tool by Genomenon. Continue Reading….
February 19, 2019 – Genomenon and Diploid Sign Partnership Agreement to Accelerate Rare Disease Diagnostics
Genomenon and Diploid announced today that the Mastermind Genomic Search Engine has been integrated Into Diploid’s Moon diagnostic software, an advancement that will improve genome interpretation for rare disease diagnostics. Continue Reading….
Genomenon announced today that industry veteran David Anstey has joined the executive team as the company’s Vice President of Sales. In his new role, Anstey is responsible for building out and leading the company’s sales and business development efforts. Continue Reading….
January 17, 2019 – Emergence of Cancer Drug Resistance and Focus on Rare Diseases Found in 2018 Published Research
Genomenon has released a research report detailing the top emerging genomic variants in 2018. This year’s data showed a continued trend of studies and new discoveries detailing variants that are becoming increasingly resistant to drugs. The report was compiled using the research data found in the Mastermind® Genomic Search Engine. Continue Reading….
Genomenon® announced that it has completed a $2.5M equity financing round. Investors in this round include IrishAngels, H. W. Kaufman Group, and all of Genomenon’s earlier investors including the company’s CEO, Mike Klein. The company initially set out to raise $2.0M in new financing, but with strong interest from both current and new investors, the round was oversubscribed. Continue Reading….
Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The term “variant” refers to a genomic mutation in the DNA – key data used in searching for causes of cancer and rare diseases. Continue Reading….
October 29, 2018 – GenomOncology and Genomenon Partner to bring Genomic Literature Search to Molecular Tumor Board
GenomOnocology and Genomenon® announced today a partnership that incorporates Mastermind® Genomic Search Engine results into GenomOncology’s Molecular Tumor Board. The goal of the partnership is to put the most up-to-date genomic research at the fingertips of oncologists making treatment decisions for critically ill cancer patients. Continue Reading….
October 18, 2018 – Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation
Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant classification. Continue Reading….
October 16, 2018 – Genomenon Partners with Rare Genomics Institute, Begins with Philanthropic Donation
Genomenon announced today that they will donate Mastermind Genomic Search Engine licenses to the entire team of clinical scientists at Rare Genomics Institute to accelerate their work for patients with rare diseases. Continue Reading….
Genomenon, Inc. has been selected as a 2018 TiE20 Winner for the prestigious TiE20 Awards Program. The company has been recognized for its work in Next Generation Sequencing (NGS) interpretation with the Mastermind Genomic Search Engine. Mastermind assists doctors and researchers in connecting patient DNA with the most relevant medical research. The competition is a part of TiECon Detroit 2018, Michigan’s largest conference for entrepreneurs. Continue Reading….
September 18, 2018 – Genomenon Advances its Genomic Search Engine for Pharma and Diagnostic Labs with Supplemental Data
Mastermind Genomic Search Engine indexes 500,000 new genomic variants from supplemental data found in scientific publications. Researchers and clinicians can now use the Mastermind Genomic Search Engine to expand their search into the supplemental materials that are often published alongside research papers and frequently contain vast collections of genomic information. Continue Reading….
July 31, 2018 – Genomenon Awarded Phase 2 NIH Grant to Apply Artificial Intelligence to Genomic Interpretation
Genomenon, the leading genomic data search company, today announced that it was awarded a Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). Continue Reading….
June 26, 2018 – The University of Vermont Health Network Standardizes on Genomenon’s Mastermind Genomic Search Engine
Genomenon announced today that the University of Vermont Health Network has selected Genomenon’s Mastermind Genomic Search Engine as their standard for searching medical literature for variant interpretation within the Department of Pathology and Laboratory Medicine. Continue Reading….
Through the Fluidigm-Genomenon joint panel design services offering, researchers will be able to accelerate the design of disease-specific next-generation sequencing (NGS), genotyping, and real-time PCR panels for use with highly efficient Fluidigm® automated microfluidic systems. Continue Reading….
May 23, 2018 – Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels
Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies Continue Reading….
April 24, 2018 – Genomenon’s Machine Learning Algorithm Identifies Key Biomarkers for Rare Genetic Disorders of Obesity
Genomenon, the leading genomic data search company, today announced a partnership with Rhythm Pharmaceuticals, a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, to create a database of genetic mutations associated with obesity as documented in the medical literature. Continue Reading….
Mastermind Uses Machine Learning to Prioritize Medical Literature According to ACMG Variant Interpretation Guidelines Continue Reading….
April 2, 2018 – Genomenon Partners with Veritas Genetics to Create Next Generation Genomic Literature Prioritization Engine Powered By Machine Learning and AI
Companies Collaborate to Aggressively Reduce the Time and Cost of Variant Interpretation to Further Scale Global Adoption of Whole Genome Sequencing Continue Reading….
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis. Continue Reading….
The Mastermind now provides a link to VarSome for gene and variant information from 30 different genomic databases. VarSome includes a link to Mastermind search results for the scientific literature related to each variant and gene in VarSome. Continue Reading….
Genomenon Presents Details of a Pan-Hematopoietic Malignancy Gene Panel with with Supporting Evidence. Continue Reading….
October 18th, 2017 – LifeOmic Leverages Genomenon’s Mastermind Genomic Search Engine for Variant Intrepretation
LifeOmic Partners with Genomenon to Streamline Genomic Interpretation of Whole Genomes Continue Reading….
Genomenon is offering a Free Edition of the Mastermind Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis. Continue Reading….
New Product Dramatically Accelerates Genetic Variant Curation – Speeding Time to Patient Diagnosis. Continue Reading….
Genomenon Inc., a DNA interpretation software company, today announced the completion of a $1.8M investment. Continue Reading….
Genomenon’s Board of Directors recently appointed Mike Klein to the position of Chief Executive Officer as the company prepares to launch its first product, Mastermind, the worlds first genomic search engine. Continue Reading….